Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.
Also called NCT04707352
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 162 participants
- Registry
-
NCT04707352
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT04707352. Allocation not applicable; no masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2023-03-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .
- Acronym
- MODA
- Condition
- Heart Failure
- Intervention (Drug)
- Dapagliflozin
- Lead sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Collaborator
- Spanish Society of Cardiology
Record details
- Record id
cardio:ct-nct04707352- Content hash
ff30d006071f7ef2c955616c57dc4b7ef225e6425266cfe2fd8a77c99fe4f8c7